| Literature DB >> 24368938 |
Ganesh Gunasekaran1, Jyoti Sharma1, Leandro C Mosna1, Roxana Bodin1, David C Wolf1.
Abstract
During orthotopic liver transplantation (OLT), biliary tract perfusion occurs with hepatic artery reperfusion (HARP), commonly performed after the portal vein reperfusion (PVRP). We examined whether the average time interval between PVRP and HARP impacted on postoperative biliary strictures occurrence. Patients undergoing OLT from 2007 to 2009 were included if they were ≥18 years old, had survived 3 months postoperatively, and had data for PVRP and HARP. Patients receiving allografts from DCD donors were excluded. Patients were followed for 6 months post-OLT. Seventy-five patients met the study inclusion criteria. Of these, 10 patients had a biliary stricture. There was no statistical difference between those with and without biliary stricture in age, gender, etiology, MELD score, graft survival, and time interval between PVRP and HARP. Ninety percent of patients with biliary stricture had a PVRP-HARP time interval >30 minutes, as opposed to 77% of patients without biliary stricture. However, this was not statistically significant. The cold ischemia time was significantly different between the two groups. Time interval for HARP after PVRP did not appear to affect the development of biliary strictures. However, 30 minutes may be suggested as a critical time after which there is an increase in biliary stricture occurrence.Entities:
Year: 2013 PMID: 24368938 PMCID: PMC3866776 DOI: 10.1155/2013/757389
Source DB: PubMed Journal: J Transplant ISSN: 2090-0007
Descriptive characteristics of patients with and without biliary strictures undergoing OLT from 2007 to 2009.
| Variable | OLT without biliary strictures ( | OLT with biliary strictures ( |
|
|---|---|---|---|
| Age, years, mean ± sd (range) | 55.0 ± 11.3 (18.0–75.0) | 55.0 ± 9.9 (37.0–70.0) | 0.99 |
| Male, % ( | 72.3 (47) | 80.0 (8) | 0.60 |
| Etiology, % ( | |||
| HCC | 27.7 (18) | 30.0 (3) | 0.57 |
| ALF/fulminant | 4.6 (3) | 10.0 (1) | 0.44 |
| HCV/ETOH | 4.6 (3) | 10.0 (1) | 0.44 |
| HCV | 21.5 (14) | 20.0 (2) | 0.63 |
| HBV | 3.1 (2) | 0.0 (0) | 0.75 |
| PSC | 3.1 (2) | 0.0 (0) | 0.75 |
| NASH | 3.1 (2) | 0.0 (0) | 0.75 |
| Cryptogenic | 10.8 (7) | 20.0 (2) | 0.34 |
| MELD, mean ± sd (range) | 21.4 ± 10.5 (6.0–44.0) | 24.3 ± 12.7 (6.0–48.0) | 0.42 |
| Graft survival, months, mean ± sd (range) | 24.9 ± 9.5 (3.0–45.0) | 24.9 ± 9.6 (12.0–40.0) | 0.99 |
| Alive, % ( | 86.2 (56) | 90.0 (9) | 0.74 |
| PVRP-HARP, minutes, mean ± sd (range) | 48 ± 29 (10–189) | 50 ± 26 (26–119) | 0.81 |
| Warm ischemia time (WIT; minutes) mean ± sd (range) | 41.3 ± 7.8 (20–60) | 46.8 ± 12.2 (36–69) | 0.06 |
| Cold ischemia time (CIT; minutes) mean ± sd (range) | 407.9 ± 126.6 (38–756) | 501.5 ± 125.9 (277–631) | 0.03* |
*Statistically significant.
Figure 1Range of PVRP-HARP time intervals in OLT patients with biliary strictures (N = 10) from 2007 to 2009.
Comparison of various PVRP-HARP time intervals and frequency of biliary strictures in OLT patients (n = 75) from 2007 to 2009.
| Biliary strictures | |||||
|---|---|---|---|---|---|
| NO | YES | Pearson's chi test |
| ||
| Time interval between PVRP-HARP (minutes) | <30 | 15 | 1 | 0.88 | 0.68 |
| ≥30 | 50 | 9 | |||
| <48 | 38 | 6 | <0.000 | 1.00 | |
| ≥48 | 26 | 4 | |||
| <60 | 46 | 7 | 0.002 | 1.00 | |
| ≥60 | 19 | 3 | |||